Components of the gut microbiome could be used to better predict efficacy of CAR-T cell therapy

Even though, according to recent preliminary studies, the risk of dying from cancer has declined within the European Union in recent years, cancers remain among the leading causes of death.

Related Keywords

Heidelberg ,Baden Wüberg ,Germany ,Munich ,Bayern ,Israel ,Emily Henderson ,Cancer Research Industry ,University Hospital Munich ,University Hospital Heidelberg ,Md Anderson Cancer Center ,Moffitt Cancer Center ,Weizmann Institute Of Science Israel ,University Hospital ,Cancer Research ,European Union ,University Hospital Regensburg ,Research Industry Focus ,Weizmann Institute ,Hospital Munich ,Cancer Center ,United States ,Cancer ,Icrobiome ,Ntigen ,Bacteria ,Fell ,Hospital ,Immunotherapy ,Lymphoma ,